Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Venture Construction Group Sponsors ALS Therapy Development Institute Fundraiser


News provided by

Elev8 Consulting Group

Nov 19, 2015, 12:15 ET

Share this article

Share toX

Share this article

Share toX

www.VentureBuilt.com
www.VentureBuilt.com

“I understand the frustrating journey that families and friends go through when a loved one is diagnosed with ALS. I'm determined to help beat this disease by supporting ALS research," says Steve Shanton, CEO and founder of Venture Construction Group.

Post this

BOSTON (PRWEB) November 19, 2015 -- Venture Construction Group sponsored the fifth annual ALS Therapy Development Institute’s A White Coat Affair gala on November 14th at 6 p.m. at the Sheraton Boston hotel in Boston to raise funds for ALS research. The annual event had over 500 attendees and raised nearly $500,000. Venture Construction Group purchased a table as a Copper Sponsor for those living with ALS to attend. Sponsorship recipients included event speaker Andrea Peet and her family and friends. Peet was diagnosed with ALS in 2014 at the age of 33, less than one year after completing five triathlons in one season, including the 70.3 mile half Ironman. Peet spoke about her journey and asked attendees to support research.

“Andrea Peet, a person living and coping with ALS, was able to attend the event because of Mr. Shanton’s generosity. She gave a speech at the event that left not a dry eye in the house. Today, our scientists have access to an unprecedented amount of data in ALS that we are using expeditiously towards discovering therapies for people like Amanda who are living with this disease. We rely on the growing support of our communities, sponsors and partners to raise funds for this crucial research,” said Steve Perrin, Ph.D., CEO and CSO of the ALS Therapy Development Institute.

To date, the annual A White Coat Affair event has raised over $1,400,000 to accelerate the development of therapies at the ALS Therapy Development Institute. Part of the ALS network, thousands of supporters have joined the Institute since 2011 to honor the people facing ALS; celebrate progress, and join in the fight to change the prognosis of this disease.

According to the ALS Therapy Development Institute, there is only a single medicine for specifically treating ALS - riluzole. The drug, marketed by Sanofi-Aventis under the name Rilutek, extends life by only about 2 to 3 months. The urgent unmet medical need for more effective treatments for this devastating and fatal disease is the basis for the research and drug development effort at the nonprofit biotech organization, ALS Therapy Development Institute.

“I understand the frustrating journey that families and friends go through when a loved one is diagnosed with ALS. My dad was diagnosed with ALS in 2010 and passed away in 2012. Watching him endure this was painful. It totally changed my life and I know there are many out there going through this. I am determined to help beat this disease by supporting ALS research to help find a cure and help others who are enduring this,” says Steve Shanton, CEO and founder of Venture Construction Group.

A huge advocate for ALS research, Venture Construction Group sponsors numerous charitable events throughout the country, including the ALS Therapy Development Institute’s A White Coat Affair on November 14, 2015 in Boston, Massachusetts; the Ride to Defeat ALS in Tampa, Florida on November 7, 2015; the Walk to Defeat ALS in Miami-Dade county on September 26, 2015; the ALS Classic Golf Tournament on September 9, 2015 in Greater Chicago, Illinois; the ALS Express-Ride to Defeat ALS in New Jersey on May 30, 2015; the Fiesta 5K Run for ALS Research in Baltimore, Maryland on May 2, 2015; the Walk to Defeat ALS in West Palm Beach, Florida on March 21, 2015.

Collectively, Venture Construction Group has donated tens of thousands of dollars to numerous charities throughout the country including the ALS Association, ALS Therapy Development Institute, Robert Packard Center for ALS Research at Johns Hopkins, Luke’s Wings, the National Multiple Sclerosis Society, Susan G. Komen, Friends in Pink, SafeSpace, Girl Scouts, Jrc Charitable Foundation, ARC, and more. Giving back to philanthropic charities and helping others is an integral part of the company’s mission.

In addition to providing construction, renovation and restoration services nationwide, Venture Construction Group helps property owners recover quickly after storm events such as hail, tornadoes, hurricanes, wind, fire and flood. Venture Construction Group services the East Coast, Greater Mid-Atlantic Region, Gulf Coast, and Midwest including New York, Pennsylvania, New Jersey, Virginia, Maryland, Washington D.C., New Hampshire, Massachusetts, Rhode Island, Connecticut, West Virginia, Oho, North Carolina, South Carolina, Georgia, Florida, Wisconsin, Illinois, Texas.

About the ALS Therapy Development Institute
The ALS Therapy Development Institute and its scientists actively discover and develop treatments for ALS. The Institute is the world’s first and largest nonprofit biotech focused 100 percent on ALS research. Led by ALS patients and their families, the charity understands the urgent need to slow and stop this horrible disease. Based in Cambridge, MA, the Institute has served as one of the leaders in sharing data and information with academic and ALS research organizations, patients and their families. For more information, visit http://www.als.net.

About Venture Construction Group
Venture Construction Group is a national leader in residential and commercial construction, renovations, insurance restoration, storm damage repairs, and 24/7 emergency services. We are a full-service general contractor and assist property owners with all of your construction and restoration needs. Operational excellence is our mission in every project we undertake, and we pride ourselves on providing exceptional customer service to property owners nationwide. With our expert team of HAAG Engineering residential and commercial certified inspectors, we take care of your project every step of the way. Whether you have a new construction project, renovation, storm damage, hail damage, water damage, wind damage, or just require a reputable roofing contractor, we are here to help. Venture Construction Group is proud to be an exclusive certified National Storm Damage Center preferred contractor, a certified contractor with the National Insurance Restoration Council, a member of the United Association of Storm Restoration Contractors, and Platinum Preferred Contractor with Owens Corning Shingles. With offices nationwide and a solid reputation throughout the country, we are able to respond to your needs with quality, ease, and top-notch service. For more information call 1-866-459-8348 or visit us online at http://www.VentureBuilt.com.
Media Inquiries:

Nina Tomaro
Elev8 Consulting Group
Ph: 386-243-5388
Em: [email protected]
Web: http://www.elev8cg.com

###

Nina Tomaro, Elev8 Consulting Group, http://www.elev8cg.com, +1 386.243.5388, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.